Work

Imatinib-treated chronic myeloid leukemia patients with discordant response between cytogenetic and molecular tests at 3 and 6 month time-points have a reduced probability of subsequent optimal response

Year: 2015

Type: article

Abstract: of subsequent optimal response

Source: Haematologica

DOI: 10.3324/haematol.2015.124685

Authors: Massimiliano Bonifacio, Gianni Binotto, Elena Maino, Elisabetta Calistri, Luciana Marin, Luigi Scaffidi, Luca Frison, Federico De Marchi, Mauro Krampera, Giampiero Semenzato, Renato Fanin, Achille Ambrosetti, Mario Tiribelli

Institutions: University of Verona, University of Padua, Ospedale dell' Angelo, Ca' Foncello Hospital, University of Udine, Azienda sanitaria universitaria Friuli Centrale

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,157

OpenAlex ID: W1984695431

FWCI: 2.041

Cites: 13

Cited by: 10

Related to: 10